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Abstract
Macrophages are professional phagocytic cells that orchestrate innate immune responses and 
display remarkable phenotypic diversity at different anatomical locations. However, the 
mechanisms that control the heterogeneity of tissue macrophages are not well characterized. Here, 
we report that the nuclear receptor LXRα is essential for the differentiation of macrophages in the 
marginal zone (MZ) of the spleen. LXR deficient mice are defective in the generation of MZ and 
metallophilic macrophages, resulting in abnormal responses to blood-borne antigens. Myeloid 
specific expression of LXRα or adoptive transfer of wild-type monocytes rescues the MZ 
microenvironment in LXRα deficient mice. These results demonstrate that LXRα signaling in 
myeloid cells is crucial for the generation of splenic MZ macrophages and reveal an 
unprecedented role for a nuclear receptor in the generation of specialized macrophage subsets.
Introduction
Macrophages have long been recognized as key components of cellular immunity. As 
sentinels of the immune system distributed throughout the body, macrophages ensure tissue 
integrity by scavenging altered host components, foreign materials and organisms1. 
Macrophages direct anti-microbial actions through the production of cytotoxic species, 
cytokines and chemokines that are required for the initiation and persistence of acute and 
chronic inflammation2. Macrophages, also contribute to immune suppression and self 
tolerance by removing apoptotic cells under non-inflammatory conditions3.
Tissue macrophages were traditionally categorized as part of the mononuclear phagocyte 
system and have been generally considered to be derived from circulating monocytes or 
myeloid progenitor cells4. Monocytes and resident macrophages are largely dependent on 
macrophage colony-stimulating factor (CSF-1) and its receptor CSF-1R (also called CD115 
or c-fms) for their differentiation and/or survival1. Tissue macrophages display a high 
degree of heterogeneity, a feature that reflects the individual functions of specialized 
macrophage populations at different anatomical locations4, 5. Functional diversity of 
macrophage populations is presumably determined by local signals present only under 
specific developmental, homeostatic or pathological tissue scenarios4–6. However, the 
molecular programs that control macrophage specialization and function in different tissues 
remain poorly defined.
The spleen is the largest secondary lymphoid organ in the body and is important for the 
generation of immune responses to blood-borne antigens and for filtering the blood of 
senescent cells or potentially noxious material7. These functions are linked to the phagocytic 
capacity of specific macrophage subpopulations that are compartimentalized into different 
splenic domains, including the red pulp (RP), the marginal zone (MZ) and the white pulp 
(WP)1, 7, 8. RP macrophages, defined by the expression of F4/80 and CD68 antigens, are 
critical for the phagocytosis of effete red blood cells and contribute to iron recycling9. In 
contrast, tingible body macrophages in the WP of the spleen express less F4/80 but express 
abundant CD68 and MFG-E8 and are involved in the engulfment of apoptotic lymphocytes 
generated during germinal center immune reactions9. The MZ is located at the interface of 
the WP and the RP where most of the arterial blood that enters the spleen can be screened by 
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several resident cell types, including two subsets of macrophages and a population of MZ B 
cells8, 10. Macrophages in this area form two concentric rings and present a special 
combination of surface receptors: MZ macrophages are characterized by the expression of 
SIGN-R1 and MARCO, whereas metallophilic macrophages express CD169. Based on their 
strategic position and their unique expression of pattern recognition receptors, MZ 
macrophages are believed to participate in many aspects of host immunity8, 9. The molecular 
and transcriptional regulators responsible for the generation of MZ macrophages remain 
undefined.
The Liver X receptors (LXRα, encoded by the gene Nr1h3, and LXRβ, encoded by the gene 
Nr1h2) are members of the nuclear receptor superfamily of transcription factors that play 
key roles in the control of sterol homeostasis11. LXRβ is expressed ubiquitously and LXRα 
is highly expressed in the liver, adipose tissue, intestine, and differentiated 
macrophages11, 12. In macrophages, where both LXRα and LXRβ are highly expressed, the 
two receptors transactivate a similar gene program, with the exception of the LXRα-specific 
target, Cd5l12. LXRs also regulate gene expression through a process known as 
transrepression13, 14 and are important for the transcriptional responses of macrophages 
during engulfment of apoptotic cells15. Loss of LXRα and LXRβ in mice results in 
peripheral lipid accumulation and symptoms of immune overreaction that aggravate with 
age, culminating in systemic autoimmunity15–17. Since both LXRs activate and repress 
similar genetic programs in macrophages, it has been assumed that their functions in 
macrophages are largely redundant. Here, we demonstrate that expression of LXRα, but not 
LXRβ, in myeloid cells is crucial for the development of macrophages in the marginal zone 
of the spleen. Our results outline an unexpected role for a nuclear receptor in the genesis of 
tissue macrophage diversity.
Results
Absence of Marginal-Zone macrophages in LXR-deficient mice
To investigate a possible role of LXRs in the development of resident macrophages, tissue 
sections from wild-type and Nr1h3−/− Nr1h2−/− mice (lacking both LXRα and LXRβ, 
hereafter LXR-DKO) were screened by immunohistochemical analysis with monoclonal 
antibodies that recognize macrophage surface antigens1. Expression of F4/80 and CD68 
markers was similar in wild-type and LXR-DKO tissues (Supplementary Fig. 1). 
Surprisingly, we found a complete absence of CD169+ macrophages in the spleens of LXR-
DKO mice (Supplementary Fig. 1). In contrast, macrophages with CD169 expression were 
detected in several other tissues of LXR-DKO mice, such as lymph nodes, Peyer’s patches, 
liver or intestine (Supplementary Fig. 1 and 2a). To further evaluate the impact of LXR 
expression on the development of the splenic macrophage repertoire, we used a combination 
of flow cytometry, immunofluorescence and immunohistochemical approaches. Expression 
of surface markers F4/80+, CD11b+ and CD68+ and the microanatomical location of these 
cells were comparable between wild-type and LXR-DKO spleens, suggesting that LXR 
signaling was not involved in the development of RP and WP macrophages under steady-
state conditions (Fig. 1a, b). However, the distinctive microenvironment of the splenic MZ 
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was remarkably altered in LXR-DKO spleens (Fig. 1a, c). Indeed, expression of CD169, 
MARCO, SIGN-R1 and Tim-4 was selectively lost in LXR-DKO spleens (Fig. 1a–c).
Dysregulation of these phagocytic markers could reflect that their expression might be 
transcriptionally controlled by LXR signaling or that the cells expressing these proteins 
could be absent in LXR-DKO spleens. Expression of mRNA encoding MARCO, SIGN-R1 
and CD169 was similar in LXR-DKO peritoneal macrophages compared to wild-type 
controls (Fig. 2a). In addition, the MZ space between the RP (containing cells positive for 
F4/80 or VCAM-1) and the border of the WP (delineated by MadCAM-1+ cells18), was 
virtually absent in LXR-DKO spleens (Fig. 2b). Hematoxilin and eosin staining and 
transmission electron microscopy further supported our finding that LXR signaling was 
crucial for the establishment of macrophages in the splenic MZ (Fig. 2b). Subpopulations of 
splenic dendritic cells (DCs) such as follicular DCs detected by FDC-M1, FDC-M2 
markers19 or Treml4+ cells20 were also not different between wild-type and LXR-DKO 
spleens (Supplementary Fig. 2b).
Loss of MZ macrophages in LXR-DKO mice could be attributed to a defect in the local 
microenvironment (stromal non-hematopoietic network) or to deficient differentiation of 
hematopoietic precursors. Although the number of blood granulocytes was higher in LXR-
DKO mice in agreement with previous work16, no major defects in the frequency of BM or 
peripheral blood monocytes and myeloid progenitors were observed in LXR-DKO mice 
compared to wild-type controls (Supplementary Fig. 3). Next, we generated hematopoietic 
chimeras by transplanting bone marrow (BM) from either wild-type or LXR-DKO donors 
into irradiated wild-type and LXR-DKO recipients. Development of MZ macrophage 
populations was observed in LXR-DKO mice reconstituted with wild-type BM but not with 
LXR-DKO BM (Fig. 2c). Moreover, transplantation of LXR-DKO BM into wild-type mice 
led to an important disruption of the MZ microenvironment (Fig. 2c). These findings 
strongly suggest that the absence of MZ macrophages in LXR-DKO mice results from an 
intrinsic hematopoietic defect.
MZ B cells and capture of blood-borne antigens
Previous work suggested that crosstalk between MZ macrophages and a population of non-
recirculating MZ B cells was important for the retention and function of both cell types in 
the spleen21–23. MZ B cells are characterized by their localization and CD1d+ IgMhi CD21hi 
CD23lo IgDlo expression pattern10. To evaluate the impact of MZ macrophage loss on MZ B 
cell localization and frequency, wild-type and LXR-DKO spleen sections or cell suspensions 
were compared by immunofluorescence, immunohistochemistry and flow cytometry 
analysis. The fraction of B220+CD21hiCD23lo MZ B cells was reduced in LXR-DKO spleen 
cells compared to wild-type controls (Fig. 3b). Surprisingly, the B220+CD1d+IgMhi B cell 
population (which normally resides outside the white pulp), was confined to the inner border 
of the follicles in LXR-DKO spleens (Fig. 3a). Since MZ B cells have been functionally 
linked to immune responses against thymus-independent (TI) antigens8, 10, we evaluated the 
response of wild-type and LXR-DKO mice to trinitrophenyl (TNP)-conjugated Ficoll type-2 
TI antigen. IgM titers in response to TNP-Ficoll immunization were significantly reduced in 
LXR-DKO mice compared to wild-type controls (Fig. 3c). These results indicate that LXR 
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signaling is important for the retention of MZ B cells within their splenic anatomical 
compartment and also participates in early IgM responses to TI antigens.
Because a rapid clearance of blood-borne antigens by MZ macrophages is important to 
prevent dissemination of potentially harmful agents, we investigated the ability of LXR-
DKO mice to recognize and clear blood antigens in the absence of MZ macrophages. A 
panel of intravenously injected bacterial or yeast components, inactivated microorganisms 
and opsonized particles were efficiently captured by splenic macrophages and generally 
colocalized with MZ macrophages in wild-type mice. By contrast, circulating antigens 
aberrantly percolated into the RP of LXR-DKO mice and appeared widely dispersed and 
associated with F4/80+ macrophages (Fig. 4a, b and Supplementary Fig. 4). These data 
show that intact LXR signaling is required for the generation of an efficient network of 
scavenging macrophages in the spleen.
Development of MZ macrophages is dependent on LXRα signaling
To determine if the MZ macrophage defect observed in LXR-DKO mice was dependent on 
one of the two LXRs, sections from wild-type, Nr1h3−/− (LXRα-KO), Nr1h2−/− (LXRβ-
KO), or LXR-DKO spleens were analyzed by a combination of immunofluorescence and 
immunohistochemistry approaches. Surprisingly, LXRα-KO mice exhibited a selective 
ablation of MZ macrophages that was virtually identical to that observed in LXR-DKO mice 
(Fig. 5a, top). Moreover, immunohistochemistry and immunofluorescence analysis revealed 
that the establishment of the MZ space between the WP and RP areas was also LXRα-
dependent (Fig. 5a, middle and bottom and Supplementary Fig. 5). Consistent with these 
observations, transplantation of LXRβ-KO BM into LXR-DKO recipients led to a recovery 
of the MZ space and MZ macrophages, whereas LXRα-KO donor BM could not rescue the 
MZ microarchitecture (Fig. 5b top, middle). Moreover, transplantation of LXRβ-KO BM 
(but not with LXRα-KO) into LXR-DKO mice restored the efficient capture of blood-borne 
antigens and the induction of IgM responses coinciding with the replenishment of MZ 
macrophages (Supplementary Fig. 6). Interestingly, reconstitution with BM from either 
LXRα-KO or LXRβ-KO donors reduced neutral lipid accumulation in LXR-DKO spleens, 
indicating that, while LXRα is uniquely required for the development of MZ macrophages, 
regulation of cholesterol metabolism in the spleen can be controlled by either LXRα or 
LXRβ (Fig. 5b bottom).
To confirm the importance of hematopoietic LXRα signaling in the generation of MZ 
macrophages, we used Cre-lox technology to create a conditional knockout mouse line with 
selective ablation of LXRα in hematopoietic cells (Supplementary Fig. 7). Mice 
homozygous for the Nr1h3 floxed allele (Nr1h3fl/fl) were crossed with transgenic mice 
expressing Cre Recombinase under the control of Vav1 promoter (Vav-Cre)24. LXRα 
deletion efficiency in Nr1h3fl/fl/Vav-Cre+ (hematopoietic LXRα knockout, Hem-LXRα KO) 
was greater than 95% at the mRNA level in BM and spleen (Supplementary Fig. 7b). 
Expression of the LXRα-specific target Cd5l25 was used as an additional control of LXRα 
activity. Immunoblot analysis using an LXRα specific antibody26 (Supplementary Fig. 8) 
confirmed a high degree of LXRα deletion in macrophages and in the spleen (but only 
minimally affected in the liver) of Hem-LXRα KO mice (Fig. 6a top and Supplementary 
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Fig. 7b). Development of F4/80+ RP macrophages was unaffected in Hem-LXRα KO mice, 
but there was a complete loss of MZ macrophages (Fig. 6a, bottom).
To gain insight into the cellular mechanisms controlled by LXRα signaling that lead to the 
development of MZ macrophages, we overexpressed LXRα in hematopoietic stem cells 
(HSCs) using a myeloid specific lentiviral system27,28. First, we examined the expression of 
the green fluorescent protein (GFP) in blood monocytes obtained from mice transplanted 
with HSC-enriched BM cells that were previously transduced with the myeloid specific 
lentivirus. Eight to twelve weeks after transplant, around 40% of monocytes were GFP+ 
(Fig. 6b top and data not shown). Next, we used lentivirus expressing GFP (Lenti-GFP) or 
LXRα (Lenti- LXRα) to transduce HSC-enriched BM cells obtained from LXRα-KO donor 
mice and performed reconstitution studies in a cohort of LXRα-KO recipient mice. Analysis 
of spleen sections revealed a partial recovery of CD169, MARCO and Tim-4 expressing 
cells in the MZ compartment in mice transplanted with Lenti-LXRα transduced cells (Fig. 
6b). These results indicate that LXRα expression in hematopoietic cells is important for the 
generation of MZ macrophages.
Wild-type monocytes replenish MZ macrophages in LXRα-KO mice
Although it is generally assumed that BM-derived monocytes give rise to macrophages in 
vivo4, a direct link between emigrated monocytes and the differentiation of splenic MZ 
macrophages under steady-state conditions has not yet been established5. We evaluated 
whether the frequency of the classical CD115+Ly6Chi and the nonclassical CD115+Ly6Clo 
monocyte subsets might be altered in LXRα-KO mice. Flow cytometry analysis 
demonstrated that CD115+Ly6Chi and CD115+Ly6Clo populations were present at similar 
frequencies in BM and blood of wild-type and LXRα-KO mice (Fig. 7a). Surprisingly, an 
increase in splenic monocytes was observed in LXRα-KO mice, an effect that was restricted 
to the nonclassical CD115+Ly6Clo subset (Fig. 7a). Thus, the absence of MZ macrophages 
in these mice cannot be accounted by the absence of monocytic precursors.
Next, we tested the potential of mature monocytes to drive the generation of MZ 
macrophages under steady-state conditions. We first analyzed the ability of i.v.-transferred 
(DsRed+ or GFP+) BM or splenic monocytes to arrive at representative target tissues of 
recipient mice. Although each monocyte presented a preferential tropism for their source 
tissue, both BM and spleen donor monocytes were able to home to the spleen of recipient 
mice at comparable rates (data not shown). Purified wild-type BM or spleen monocytes 
(CD115+CD11b+ donor cells) were then evaluated for their potential as MZ macrophage 
precursors in adoptive transfer experiments in nonirradiated LXRα-KO recipient mice. 
Notably, twelve weeks after transfer, both spleen or BM monocytes from wild-type donors 
partially reconstituted CD169+ and MARCO+ cells in the MZ space of LXR-KO mice (Fig. 
7b). Additional transfer experiments demonstrated that monocyte-dependent replenishment 
of MZ macrophages in LXR-DKO mice leads to a partial recovery of the MZ B-cell 
compartment (data not shown). Together, these data suggest that monocytes coming from 
the circulation can generate MZ macrophages that are functionally competent.
Because Ly6Chi and Ly6Clo monocytes have been proposed to play distinct roles in 
inflammation6, we used our LXRα-KO model to investigate whether these monocyte 
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subsets exhibited differential capacity to generate MZ macrophages. BM CD115+CX3CR1lo 
and CD115+CX3CR1hi monocytes (corresponding to Ly6Chi and Ly6Clo subsets, 
respectively) promoted the development of MZ macrophages with similar efficacy 
(Supplementary Fig. 9a). Furthermore, purified Ly6Chi and Ly6Clo spleen monocytes 
showed equivalent mRNA expression of LXRα, LXRβ and ABCA1 (but not CCR2 which 
was used as a control to distinguish Ly6Chi and Ly6Clo monocytes; Supplementary Fig. 9b). 
These results suggest that classical and nonclassical monocytes may play redundant roles in 
the differentiation of certain macrophage subsets under steady-state conditions. However, 
since Ly6Chi have been shown to generate Ly6Clo monocytes29, 30, we cannot exclude that 
Ly6Clo monocytes are the immediate precursors of MZ macrophages in LXRα-KO mice in 
our experimental model.
Activation of LXRα accelerates MZ macrophage development
Scattered macrophages can be detected during the late phases of embryonic development of 
the murine spleen, but the organization and specialization of separate splenic macrophage 
compartments occurs during the first weeks after birth7, 8. We studied the expression of 
macrophage markers in wild-type and LXR-deficient mice during the postnatal transition of 
the spleen until completion of its full mature appearance. Examination of spleen sections 
obtained from mice of 1–4 weeks of age revealed that, despite equivalent frequency of F4/80 
and CD68 expressing cells, MZ macrophages did not appear during spleen development in 
LXR-DKO mice (Fig. 8a and data not shown). Thus, LXR signaling is selectively required 
for the differentiation of MZ macrophages during the maturation of the spleen. Interestingly, 
postnatal development of MZ macrophage subpopulations correlated with a 10–12 fold 
increase in LXRα mRNA expression and no changes in LXRβ expression (Fig. 8b).
Finally, we tested the effect of genetic or pharmacological activation of LXRα on the 
development and function of MZ macrophages. Analysis of three-week old spleen samples 
from transgenic mice expressing constitutively active VP16-LXRα in macrophages and 
adipocytes (aP2-VP16LXRα31) revealed an accelerated formation of the MZ 
microenvironment with increased numbers of MZ macrophages found in their mature 
position compared to wild-type controls (Fig. 9a). Consistent with these histological 
changes, more SIGN-R1 and CD169 as well as the established LXR target ABCA1, was 
expressed in the spleens aP2-VP16LXRα mice (Fig. 9a). Since aP2 expression in monocytes 
is restricted to Ly6Clo monocytes32, it is possible that VP16-LXRα activity in the Ly6Clo 
subset contributes to accelerated MZ macrophage formation in this model. We also 
evaluated whether LXR activity is important for the functions of the MZ compartment by 
using the synthetic LXR agonist GW3965 in vivo in three different assays: Dextran-FITC 
phagocytosis, IgM response to TNP-Ficoll, and generation of MZ-B cells. Analysis of these 
activities in wild-type mice did not show differences between the agonist-treated mice and 
the control group (data not shown), indicating that supraphysiological activation of LXR 
does not alter MZ macrophage functions in adult mice. We also investigated whether 
pharmacological activation of LXRα altered the replenishment of splenic macrophages after 
experimental depletion of tissue macrophages with clodronate-containing liposomes (Clo-
lip). This acute depletion of phagocytes provides a model to analyze the progressive renewal 
of splenic macrophages in adult mice33, a process that requires 6–8 weeks for full 
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restoration of all subtypes (data not shown). We then used this Clo-lip model combined with 
administration of the dual LXR agonist GW3965 in LXRα-KO or LXRβ-KO mice in order 
to activate exclusively LXRβ or LXRα, respectively. Mice treated i.v. with Clo-lip exhibited 
a general depletion of splenic macrophages 48h post-treatment as expected33. Separate 
cohorts of LXRα-KO or LXRβ-KO mice were allowed to recover for 2 weeks after Clo-lip 
injection and then treated for one additional week with the synthetic LXR ligand GW3965 
or vehicle control. Activation of LXRβ was unable to promote the development of MZ 
macrophages in the absence of LXRα. In contrast, activation of LXRα increased the 
frequency of CD169+ and MARCO+ MZ macrophages compared to control-treated 
animals. Replenishment of F4/80+ macrophages was not altered by LXRα or LXRβ 
activation under these conditions (Fig. 9b). Interestingly, because activation of LXRα did 
not promote the expression of MZ markers in other splenic subsets (Fig. 9b), our results 
suggest that specific signals at the interface of the WP and RP are also required for the 
generation of MZ macrophages. Collectively, our results establish that LXRα is crucial for 
the generation of a specific subset of splenic phagocytes under developmental or 
homeostatic conditions.
Discussion
Tissue macrophages are a heterogeneous group of cell subsets found in all organs that 
exhibit distinct surface markers and specialized functions depending on the local 
microenvironment1, 4, 5. Several transcription factors, including PU.1, C/EBPα and Klf4 
play important roles in the differentiation of the monocyte/macrophage lineage in vitro and 
in vivo6. However, genetic models lacking these factors often exhibit profound effects on 
multiple cell types. Thus, the transcriptional programs that control the generation of 
particular resident macrophage subsets are largely unexplored. We have shown here that 
myeloid LXRα signaling is directly involved in the development of specific macrophage 
subsets important for the efficient capture of circulating antigens. To our knowledge, LXRα 
is the first gene shown to be selectively required for the development of all MZ 
macrophages in the steady-state. Our data illustrates a new physiological role for LXRα in 
myeloid cells driving the differentiation of splenic MZ macrophages. LXRα signaling in 
monocytes or myeloid progenitors is required for the production of MZ macrophages not 
only during the neonatal development of the spleen but also throughout the continuous 
renewal of these cell subsets in adult life.
Loss of MZ macrophages in LXR-deficient mice leads to a number of consequences for 
spleen architecture and physiology. First, a profound reduction of the MZ space between the 
RP and the WP affects the retention of MZ B-cells that unexpectedly relocalize to the inner 
part of the follicle in LXR-deficient mice. Although reciprocal crosstalk between myeloid 
and B-cells was previously reported to maintain MZ integrity21–23, our data suggest that the 
LXRα-dependent development of MZ macrophages provides lodging signals for the entire 
MZ niche. Second, we showed that efficient clearance of circulating particles and pathogens 
requires LXR signaling, further emphasizing the importance of MZ macrophages in the 
recognition and uptake of blood-borne antigens. Our data strongly suggest that loss of MZ 
macrophages and misplaced MZ B-cells in LXR-deficient mice constitute a permissive 
environment for many circulating pathogens.
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Consistent with an inadequate recognition of circulating antigens, the early IgM antibody 
response to TNP-Ficoll was impaired in LXR-deficient mice. Because the expression of 
marginal sinus endotelial markers is normal in LXR deficient mice, we conclude that the 
vascular network develops properly in these animals. As a consequence, blood arriving from 
the central arterioles is directly drained into the RP and possibly reaches other tissues with 
uninspected material. It is likely that the MZ macrophage deficiency described here 
contributes to the susceptibility to Listeria monocytogenes (LM) or Mycobacterium 
tuberculosis infection models observed in LXRα-KO mice25, 34. Together with previous 
studies, we propose that LXRα signaling represents an integral component of the systemic 
antimicrobial immunity, at least in part, through the regulation of splenic MZ macrophage 
development.
Although the relevance of tissue macrophage diversity has been recognized for decades4, 35, 
the origin of mononuclear phagocyte cells has recently received considerable attention5, 6. 
Whether tissue resident macrophages derive from common hematopoietic precursors or 
from yolk sac-derived precursors is a matter of intense research29, 30, 36–39. There is also 
evidence that demonstrates that macrophages can self-renew locally independently of their 
bloodstream precursors5, 40. Although similar questions relate to the origin and renewal of 
splenic murine macrophages33, 41, further complexity applies due to the number of different 
resident subsets in this tissue and the fact that the spleen continues to function as a 
hematopoietic organ in adult rodents. Our results provide the first demonstration that a 
single nuclear receptor controls the differentiation of the splenic MZ macrophage population 
through a myeloid-restricted signaling.
Several lines of evidence suggest that absence of MZ macrophages in LXR−/− mice results 
from a defective sub-lineage developmental step. Bone marrow transplant or hematopoietic 
LXRα conditional-knockout experiments indicate that LXRα-expressing myeloid cells give 
rise to MZ macrophages. A complementary gain of function approach with a macrophage-
specific lentivirus confirmed that LXRα expression in myeloid cells is necessary to 
reprogram target cells with the appropriate MZ differentiating potential in vivo. These data 
also imply that the development and organization of RP and WP macrophages in the spleen 
take place independently of the formation of the MZ and of LXRα signaling. Interestingly, 
recent studies demonstrated that differentiation of F4/80+ macrophages is impaired in Spic
−/− mice while MZ macrophages in these mice develop normally42. We interpret the 
correlation between LXRα expression and splenic macrophage compartmentalization as a 
strong evidence that supports the existence of a separate pathway controlling the generation 
of MZ macrophages.
Although monocytes contribute to increased tissue macrophage levels in several 
pathological settings43, the monocytic origin of resident macrophages in the steady-state has 
not been clearly established. We have shown that adoptively transferred wild-type 
monocytes partially reconstituted the MZ microenvironment in LXRα-KO mice. Whereas 
classical and nonclassical monocytes play distinct roles in inflammation6, 44, the ability of 
monocytes to replenish a vacant MZ microenvironment in LXRα-KO mice under 
homeostatic conditions can be accomplished by both Ly6Chi and Ly6Clo monocytes. Our 
data indicate that either circulating monocytes or local splenic monocytes can function as 
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MZ macrophage precursors under conditons of LXRα deficiency. Our findings do not 
exclude the possibility that MZ macrophages in wild-type mice may derive from embryonic 
precursors under homeostasis without contributions from circulating monocytes, as 
demonstrated for other tissue-resident populations30, 36, 39.
Finally, we found that enhancement of LXRα activity during macrophage renewal in mature 
mice led to an accelerated MZ macrophage differentiation program. Thus, intrasplenic 
induction and activation of LXRα in myeloid cells is crucial for the generation and 
maintenance of MZ macrophages both during development and in adult life. We hypothesize 
that the instructive signals that drive full maturation of monocytes into MZ macrophages and 
upregulate LXRα expression in the spleen should be released at the neonatal stage and 
remain present throughout adult life. Since oxysterols have recently been shown to influence 
various immune cell functions in vivo, including proliferation and migration45–47, it is 
tempting to speculate that spleen-specific sterol derivatives play a role in activating LXRα 
during the development of MZ macrophages. Further studies will be required to characterize 
such signals and their downstream effects in LXRα-sufficient or -deficient monocytes 
during the differentiation to splenic macrophages.
Methods
Animals
Mice were maintained under pathogen-free conditions in a temperature-controlled room and 
a 12-hour light/dark cycle. Chow and water were available ad libitum. LXRα,β- wild-type 
(Nr1h3+/+, Nr1h2+/+), LXRα-KO (Nr1h3−/−), LXRβ-KO (Nr1h2−/−) and LXR-DKO 
(Nr1h3−/−, Nr1h2−/−) mice on a mixed Sv129/C57Bl/6 and C57Bl/6 (backcrossed more 
than ten generations) backgrounds were originally obtained from David Mangelsdorf 
(UTSW)48. Mice bearing a floxed allele of LXRα (Nr1h3fl/+) on a C57Bl/6 background 
were obtained from Institut Clinique de la Souris (Illkirch, France); transgenic C57Bl/6 Vav-
Cre mice were obtained from D. Kioussis24 (NIMC, UK) through a collaboration with 
Susana Gonzalez (CNIC, Spain); transgenic mice expressing constitutively active VP16-
LXRα in macrophages and adipocytes (aP2-VP16LXRα) have been described31; 
Cx3cr1GFP/+ knock-in mice and transgenic mice expressing GFP or DsRed under the control 
of the β-actin promoter were obtained from the Jackson Laboratory. All animal studies were 
conducted in accordance with the CSIC and ULPGC Animal Research Committees.
Reagents and antibodies
The LXR (GW3965) and RXR (LG268) synthetic ligands were kindly provided by Jon 
Collins and Tim WIllson (GlaxoSmithKline SA). The following antibodies and conjugates 
were used in this study: Anti-MAdCAM-1 clone MECA-367 and anti-SIGN-R1 clone 22D1 
were obtained from the ATCC; anti-CD45R B220 clone RA3-6B2, anti-CD62L-FITC, anti-
CD11b purified and FITC conjugated Clone M1/70, anti-Ter119-FITC, anti-CD117-FITC, 
anti-CD1d (clone 1B1), anti-VCAM-1 (clone 429), anti-CD21-PE (clone 7G6), and anti-
CD23-FITC (clone B3B4) were from BD Biosciences, anti-Tim-4-PE (clone RMT4-54), 
anti MHC-II clone I-Ab, anti-IgD-FITC (clone 11-26c) were from from eBioscience; anti-
CD68 clone FA-11, anti-MOMA-1-FITC, anti-MARCO clone ED31 were from Serotec; 
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anti-F4/80 clone Cl:A3-1 and anti CD169 clone 3D6 were kindly provided by S. Gordon and 
M. Stacey (U. Oxford, UK); anti TremL4 was obtained from R. Steinman lab (Rockefeller 
NY) through Gwen Randolph (Washington University); anti-FDC-M1 and M2 were kindly 
provided by M. Kosco-Vilbois (Novimmune SA); anti-IgM-PE and anti-IgM-HRP from 
Southern Biotech; anti-mouse Laminin from Sigma; anti-Ly6C-PerCP-Cy5.5 clone HK1.4 
and anti-CD115-PE clone AFS98 and purified anti-Tim-4 clone RMT4-54 were from 
Biolegend; a Lineage cell detection cocktail containing biotinylated CD5, CD11b, CD45R, 
7/4, Gr-1 and Ter-119 antibodies was obtained from Miltenyi Biotec. Alexa Fluor 488-anti-
rat-IgG and IgM, Alexa Fluor 594- anti-rat-IgG and IgM, Alexa Fluor 350-anti rat-IgG 
(Molecular Probes), and anti-rat biotin antibody (Dako Cytomation).
Flow cytometry and progenitor assays
Bone marrow cells were obtained from femurs and tibiae by flushing with culture media. 
Blood cells were obtained by collecting EDTA-treated blood samples. Spleen cells were 
obtained using a GentleMACS dissociator and a mouse spleen dissociation kit according to 
the manufacturer instructions (Miltenyi Biotec). In all cases single-cell suspensions were 
obtained and erythrocytes lysed using a hypotonic buffer. Cells were washed and 
resuspended in PBS with 0.1% BSA and 0.1% sodium azide. Single cell suspensions were 
stained for 30 minutes at 4°C with the indicated antibodies. Cells were then analyzed on 
Beckman Coulter Epics XL, BD FACS Canto-II, BD FACS-Vantage or BD FACS-Aria 
with FlowJo software (Treestar). Monocytes were identified as CD115+CD11b+F4/80int and 
Ly6Chi or Ly6Clo. Splenic phagocytes were detected by the expression of MHCII, F4/80, 
CD68 and Tim-4 antigens. MDPs (macrophage DC progenitor) were identified as 
LineageNegCD117+CD115+. Blood counts were obtained using an Abacus automated 
hematological counter (Diatron, USA). Colony-forming units in culture (CFU-C) assays 
were determined in blood and BM samples. Briefly, blood and BM were collected and 
diluted in Lympholyte solution (Cedarlane Labs) and centrifuged to obtain mononuclear 
cells. Cells were cultured in semisolid media containing 1.25% methylcellulose (Sigma-
Aldrich), 30% FBS (StemCell Technologies), 1% BSA, 0.1mM 2-mercaptoethanol, and 
conditioned medium (12.7% v/v) from the WEHI3 cell line (expressing IL-3), HM-5 cell 
line (expressing GM-CSF) and BHK/MKL cell line stably transfected to produce KitL. 
Cultures were plated in duplicates in 35 mm culture dishes and the numbers of CFU-Cs were 
scored on day 6 or 7 using an inverted microscope.
Histology
Tissues were collected and fixed in 4% buffered formalin, dehydrated in successive alcohol 
solutions, embedded in paraffin wax, and sectioned for H&E staining. Alternatively, tissues 
were directly collected from the animal, embedded in OCT compound (Tissue-Tek), and 
snap-frozen in liquid Nitrogen and Isopentane. 4 μm frozen sections were air-dried, fixed 
with cold acetone, blocked with 6% BSA and 2% preimmune serum in PBS, and stained 
with fluorescence-conjugated antibodies diluted in blocking solution; nuclei were stained 
with DAPI (Vectashield mountain medium fluorescence with DAPI, Vector). Primary 
purified antibodies were also detected by Alexa-Fluor secondary antibodies (Molecular 
Probes). For non-fluorophore-conjugated antibodies, biotinylated secondary antibodies were 
visualized by the streptavidin-biotin-peroxidase method (Vectastain ABC Kit, Vector 
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Laboratories) and stained with the cromogen 3-30-diaminobenzidine tetrahydrochloride 
DAB or Alkaline Phosphatase (DAB HRP or Vector Blue Substrate Kits, Vector 
Laboratories). Nuclei were counterstained with hematoxilin or Methyl green (Sigma). 
Sections were observed under a Zeiss LSM 5 PASCAL Laser Scaning Microscope (Carl 
Zeiss, Germany) or Eclipse Nikon 90i (Nikon).
For transmission electron microscopy analysis, LXR wild-type and DKO mice were 
sacrified and perfused with fixation solution (2% glutaraldheyde). Spleens were fixed with 
2% OsO4, dehydrated and embedded in epoxy resin. Ultra-thin sections were stained with 
uranyl acetate and lead citrate and observed under elctron microscope at the ULPGC 
electron microcopy core facilty.
In vivo treatments
For antigen capture of circulating antigens, the following reagents were used: labeled high 
molecular weight dextran, inactivated Staphylococcus aureus, Zymosan were obtained from 
Life Technologies; GFP labeled Escherichia coli had been previously described15; platelets 
were purified by centrifugation of whole blood in Citrate-phosphate-dextrose solution. A 
platelet-rich plasma was collected and washed with PBS. Platelets were opsonized with 5μg 
anti-mouse CD41 antibody (clone MWReg30 from BD Biosciences). Antigens were 
intravenously injected into wild-type and LXR deficient mice for a 30 minute period. 
Spleens were harvested and tissues were prepared for immunofuorescence analysis as 
detailed above.
For liposome-mediated depletion of splenic macrophages, mice were injected intravenously 
with Clodronate (Cl2MBP; dichloromethylene-biphosphonate)-loaded liposomes or control 
PBS liposomes (obtained from Encapsula Nanosciences) in 200μl suspension solution. Mice 
were sacrified at the indicated times and tissues were harvested for histological analysis. For 
LXR ligand treatment in vivo after macrophage depletion with clodronate liposomes, 
GW3965 stock solution was diluted in PBS and injected 20mg/kg intraperitoneally every 2 
days for one week. Mice were sacrified and total RNA was prepared 2h after the last 
injection of ligand.
Bone marrow transplant and adoptive transfer studies
For bone marrow transplants, recipient wild-type and LXR-DKO mice (6–8 weeks of age) 
were lethally irradiated with 900 rads and transplanted with 3×106 bone marrow cells from 
6–8 week-old donors (wild-type, LXRα-KO, LXRβ-KO or LXR-DKO) by retro-orbital 
injection. Recipient mice were sacrified at 8–12 weeks after transplantation and spleen 
sections were then analyzed for the presence of macrophages as detailed above.
For adoptive transfer experiments, total monocytes from bone marrow or spleen were sorted 
on a FACS-Vantage or FACSAria (BD Biosciences) as CD11bhi, CD115hi and purity was 
greater than 90%. Cells were intravenously injected (2–3× 106 cells) into non-irradiated 
LXRα-KO mice. Recipient mice were sacrified at 8–12 weeks post-injection and spleens 
were processed as described above. For homing experiments, unfractioned splenocytes or 
bone marrow cells from GFP or Ds-Red transgenic animals were coinjected intravenously 
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into wild-type recipient mice. Target tissues were processed and the relative homing of GFP 
and Ds-Red positive monocytes was analyzed 24hr post-injection by Flow Cytometry. In 
other set of experiments, monocytes were purified from bone marrow or spleen from 
Cx3cr1GFP/+ knock-in mice. Classical CD115+CX3CR1lo and nonclassical 
CD115+CX3CR1hi monocytes were transferred (1–2×106 cells) to LXRα-KO mice. Spleens 
were isolated and analyzed by immunofluorescence as detailed above.
Lentivirus production and infection of HSC-enriched BM cells
A lentiviral system containing a macrophage-specific synthetic promoter (SP) was 
previously described in the laboratory of S. Li27. Briefly, Lenti-SP-GFP or Lenti-SP-LXRα 
constructs, were transfected with pMDlg-pRRE, pRSV/Rev and pMD2G in HEK-293 cells 
with FuGENE-HD (Promega). After 48h, supernatant was collected and viral particles were 
centrifuged at 86000xg on a SW41Ti swing bucket rotor (Beckman). Pellets were 
resuspended in StemPro 34 SFM 1%L-Glut+1%Pen+Strep and concentration of lentiviral 
particles was determined by flow cytometry analysis of transduced RAW264.7 cells with 
serially diluted lentiviral particles. To prepare cells for lentiviral transduction, total BM cells 
were enriched for HSCs by using the EasySep Hematopoietic progenitor enrichment kit 
(StemCell Technologies) or by treating donor mice with 5-Fluorouracil for four days. HSC-
enriched cells were resuspended in StemPro-34 media supplemented with 10ng/ml of IL-3, 
IL-6, IL1α and mSCF for 18 hours. Cells were then infected with Protamine Sulfate-treated 
Lenti-SP-LXRα or Lenti-SP-GFP viral particles for 24 hours. Eight hours before 
transplantation, recipient mice were irradiated as described above. Transduced HSC cells 
were resuspended in PBS and injected intravenously (2 × 106) into LXRα-KO recipient 
mice together with a fraction of LXRα-KO total BM cells (5 × 105). After 8–12 weeks mice 
were sacrified and blood and spleens were collected and tissues were processed for histology 
as described above.
Immunization and IgM determination by ELISA
To evaluate the T-independent IgM response, wild-type and LXR-DKO mice were 
immunized by intrevenous injection of 100ug of TNP-Ficoll (Biosearch Technologies). 
Serum samples were obtained before injection and on days 4 and 7 after immunization with 
TNP-Ficoll. 96-well flat-bottom plates (Nunc-immuno plate F96 MAXISORP) were 
precoated with poly-L-lysine (Sigma) for 1 hr at 37°C in a humidified chamber and were 
incubated 18hr at 4°C with a solution containing TNP-BSA as capture antigen (25ug/ml). 
After blocking the nonspecific sites with PBS containing 2% FBS and 1% BSA for 1 hr at 
37C, serial dilutions of serum samples were added for 2 hr at 20–25°C. Wells were then 
washed with PBS plus 0.05% Tween-20, and incubated with horseradish peroxidase-
conjugated goat anti-mouse IgM (diluted 1:500, Southern Biotechnology). Wells were 
developed with TMB substrate solution (3,3′,5,5′-tetramethylbenzidine). After incubation of 
5 min at 20–25°C, reaction was stopped with 50 μl of 3M H2SO4 solution and the optical 
density was measured at 450 nm in ELISA plate reader (Bio-Rad).
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DNA, RNA, and Protein Analysis
Total RNA was harvested with TRIzol reagent (Invitrogen). RNA was reverse-transcribed 
using iScript reverse-transcription kit (Bio-Rad). Real-time quantitative PCR (SYBRgreen) 
assays were performed with an Applied Biosystems 7900 sequencer detector as described 
previously15. Expression was normalized to 36B4 expression. Primer sequences are included 
in the supplemental material (Supplementary Table 1). Genomic DNA for genotyping was 
obtained from mouse tails with a PureGene mouse tail kit from Qiagen. Primers and PCR 
specifications for Nr1h3 floxed or iVav-Cre alleles were obtained from Institut Clinique de 
la Souris and S. Gonzalez (CNIC) respectively (Supplementary Table 1). For immunoblot 
analysis, peritoneal macrophages and RAW264.7 or HeLa cells stably overexpressing 
LXRα were cultured as described previously15. Whole cell lysates were obtained with RIPA 
buffer, boiled and separated on a SDS-PAGE gel. Proteins were transferred onto 
polyvinylidene difluoride membrane (Amersham), blocked in TBS with 0.1% Tween20 and 
5% milk, and incubated with the indicated antibodies. Anti-LXRα monoclonal antibody 
(clone PPZ0412, AbCAM) and anti-ABCA1 polyclonal antibody (NB400-105 Novus 
Biologicals) were used at 1:1000 and 1:3000 dilutions respectively. Blots were washed in 
TBS-T and visualized with ECL-Plus (Amersham Biosciences) and Bio-Rad Chemi-Doc 
imaging system.
Statistical Analysis
Data were expressed as mean ± SEM. Statistical analysis was performed with Student’s t 
test for two samples. For multiple comparisons, data were evaluated by one-way analysis of 
variance (ANOVA). Values of p < 0.05 were considered to be significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Defective MZ macrophage differentiation in LXR-DKO mice
(a) Top, splenic sections from wild-type (WT) and LXR-DKO mice were stained with 
specific antibodies that detect CD169+ macrophages (green) and SIGN-R1+ macrophages 
(red). Below, consecutive sections show RP macrophages (F4/80, green) and stromal 
endothelial cells (laminin, blue): CD68+ macrophages (red) and TIM-4+ cells in the MZ 
(green). Bottom, immunohistochemical analysis of RP CD11b+ cells (blue) and B cells 
(B220, brown). Arrows indicate the RP and WP borders. Scale bars represent 50 μm. (b) 
Flow cytometry analysis of F4/80, CD68, Tim-4 and MHCII expression in splenic cell 
suspensions from WT and LXR-DKO mice. Representative plots are shown from three 
independent experiments with n = 4–5 mice per genotype. Numbers within plots indicate 
percent of gated cell population (c) Immunofluorescence analysis of spleen sections from 
WT and LXR-DKO mice showing combinations of double or triple stainings with antibodies 
that recognize MZ macrophages (SIGN-R1, MARCO and Tim-4), marginal metallophillic 
macrophages (CD169) or endothelial cells (Laminin). Scale bars represent 50 μm. 
Representative images obtained from five independent experiments with n= 3–5 mice per 
genotype (a, c).
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Fig. 2. Generation of MZ macrophages require LXR function in hematopoietic progenitors
(a) Relative mRNA abundance of SIGN-R1, MARCO, Tim-4, F4/80 and CD68 in WT and 
LXR-DKO spleens (top) and peritoneal macrophages (bottom). Data are normalized to 
ribosomal protein Rplp0 (also called 36B4) mRNA expression. Bars indicate mean +/− SEM 
(n=3 mice). Data are representative of two independent experiments. (b) Hematoxilin and 
eosin staining (top), transmission electron microscopy images (second row); abbreviations: 
MZ: MZ macrophage; m: marginal metallophilic macrophage; F: follicular reticular cell; 
RB: red blood cell. RP: RP macrophage. Third row shows immunohistochemical 
localization of RP F4/80+ macrophages relative to MadCAM-1 marginal sinus cells; (bottom 
row) VCAM-1+ cells in the RP relative to laminin+ endothelial cells; scale bar represents 30 
αm. Arrows indicate RP and WP borders. Representative images obtained from three 
independent experiments with n = 2–3 mice per group. (c) Immunohistochemical 
localization of RP and MZ compartments in WT and LXR-DKO mice after reciprocal bone 
marrow transplants. Scale bar represents 50 αm. Arrows indicate the RP and WP borders. 
Marginal metallophilic macrophages (CD169, brown) and MZ macrophages (MARCO, 
blue), or RP macrophages (F4/80, brown) and endothelial cells (Laminin, blue) were stained 
in consecutive spleen sections obtained from mice 12 weeks after BM transplantation 
(representative images obtained from two independent experiments with n = 5–6 mice per 
group).
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Fig. 3. Analysis of MZ B cell distribution and function
(a) Immunofluorescence and immunohistochemical analysis of spleen sections from WT 
and LXR-DKO mice stained with antibodies that detect MZ B cells. Top, MZ B220+ B cells 
identified outside the follicles, which are delimitated by MadCAM-1+ cells in WT mice and 
absent in LXR-DKO mice; second row IgMhiIgDlo MZ B cells; third row IgMhi MZ B cells 
outside MadCAM-1+ sinus lining cells; and bottom CD1d Laminin double 
immunohistochemical analysis. Arrows indicate the RP and WP borders. Scale bars 
represent 50 μm. Representative images from n=10 mice per genotype are shown (b) Flow 
cytometry of splenocytes from WT and LXR-DKO mice stained with CD23 and CD21 
antibodies and analyzed in gated B220+ cells. MZ B cells were quantifed as CD21hiCD23lo; 
representative analysis obtained from three independent experiments of n = 3–5 mice is 
presented. (c) Mice were immunized i.v. with TNP-ficoll and serum samples were obtained 
before immunization and 4 and 7 days after immunization. TNP-specific IgM titers were 
measured by ELISA. Representative results obtained from two independent experiments 
with n = 6–10 mice per group are shown. Each (◆) symbol represents individual WT (blue, 
n = 8) or LXR-DKO (red, n = 9) mice; *P < 0.01 and **P < 0.001.
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Fig. 4. Abnormal capture of blood-borne antigens by LXR-DKO splenic macrophages
Immunofluorescence microscopy of spleen sections obtained from WT and LXR-DKO mice 
after 30 min post i.v. injection with dextran-Alexa Fluor 594 (a) and Alexa Fluor 488-
Staphyloccocus aureus particles (b). MZ macrophages were detected with SIGN-R1 (green) 
and MARCO (red) abs in (a) and (b) respectively. RP macrophages were detected with 
F4/80 antibody (green in a; red in b). Dashed lines delimitate the border of the WP and the 
RP. Scale bar represents 50 μm. Representative pictures from four independent experiments 
with n = 3–5 mice per group are presented.
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Fig. 5. MZ macrophage differentiation is specifically controlled by LXRα
(a) Top, immunofluorescence analysis of spleen sections from WT, LXRα-KO, LXRβ-KO, 
and LXR-DKO mice stained with CD169, SIGN-R1 and F4/80 antibodies. Middle, 
Immunohistochemical analysis of F4/80+ RP macrophages (brown) relative to Laminin+ 
endothelial cells (blue); bottom, consecutive sections stained for MARCO+ (blue) and 
CD169+ cells (brown). (b) Consecutive spleen sections (top, middle) show 
immunohistochemical localization of MZ macrophages (MARCO, blue and CD169, brown), 
and F4/80+ (brown) and Laminin+ endothelial cells (blue) obtained from LXR-DKO mice 
after transplant experiments with bone marrow from the indicated donor mice. Bottom, Oil-
Red O staining in spleen sections from the indicated mice after bone marrow transplantation. 
Scale bar represents 50 μm. Representative pictures from four independent experiments with 
n = 3–5 mice (panel a) and two independent experiments with n= 6 mice per group (panel b) 
are presented.
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Fig. 6. LXRα function in myeloid cells is required for MZ macrophage development
(a) Immunoblot analysis of LXRα and GADPH in peritoneal macrophages from Vav-
Cre−Nr1h3fl/fl, Vav-Cre+Nr1h3fl/+, and Vav-Cre+Nr1h3fl/fl mice. Right, relative mRNA 
abundunce of LXRα in spleen, liver and bone marrow derived macrophages (BMDM) from 
Vav-Cre−Nr1h3fl/fl, Vav-Cre+Nr1h3fl/+, and Vav-Cre+Nr1h3fl/fl mice. Data are normalized 
to 36B4 mRNA expression. Data represent mean +/− SEM (n= 2–3 mice). Data are 
representative of four independent experiments. Immunofluorescence analysis of 
consecutive sections obtained from Vav-Cre−/Nr1h3fl/fl and Vav-Cre+/Nr1h3fl/fl spleens that 
were stained with Laminin, SIGN-R1 and F4/80 antibodies (top); bottom, MZ macrophages 
(MARCO, red), and marginal metallophilic macrophages (CD169, green); scale bar 
represents 50 μm. Representative images obtained from four independent experiments with 
n = 3–6 mice per group (b) Gain-of-function studies with a macrophage specific lentivirus 
expressing LXRα. Top, flow cytometry analysis of blood monocytes from WT mice 
transplanted with HSCs transduced with Lenti-GFP viral particles. Middle, 
immunofluorescence analysis of macrophage markers in spleen sections from LXRα-KO 
mice that were transplanted with LXRα-KO HSCs transduced with Lenti-GFP or Lenti-
LXRα particles (representative images from two independent experiments with n = 4–5 
mice per group); scale bar represents 100 μm.
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Fig. 7. Adoptive transfer of monocytes reconstitute splenic MZ microenvironment in LXRα-KO 
mice
(a) Flow cytometry analysis of monocyte subsets in BM, blood and spleen cells from WT 
and LXRα-KO mice. Classical and non-classical monocytes were detected based on the 
expression of Ly6C and CD62L in CD115+ cells in BM and blood, and based on the 
expression of Ly6C in CD115+ F4/80+ cells in spleen. Bottom, percentages of classical and 
non-classical monocytes in bone marrow, blood and spleen measured by flow cytometry. 
Bars indicate mean +/− (SEM) from n = 7 mice. Data are representative from four 
independent experiments. (b) Immunofluorescence analysis of consecutive spleen sections 
from non-irradiated LXRα-KO mice reconstituted with the indicated WT monocytes from 
BM or spleen origin. Arrows indicate the RP and WP borders. Representative images from 
three independent experiments with n = 5–6 mice/group are presented. Scale bar represents 
50 μm..
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Fig. 8. LXR signaling is necessary for postnatal development of splenic MZ macrophages
a) Immunohistochemical analysis of marginal metallophilic macrophages (CD169), MZ 
macrophages (MARCO), and red pulp macrophages (F4/80) in spleen sections obtained 
from WT and LXR-DKO at the indicated times after birth; representative images from three 
independent experiments with n= 3–4 mice per genotype are presented; scale bar represents 
50 μm. (b) mRNA relative expression of LXRα, LXRβ, CD169, MARCO, in WT and 
LXRα-KO spleens at the indicated times after birth. Data represents mean +/− (SEM) 
obtained from 2 independent experiments with n = 6 mice per genotype. Data are 
normalized to 36B4 mRNA expression.
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Fig. 9. Activation of LXRα accelerates the development and renewal of MZ macrophages
(a) Immunofluorescence analysis of spleen sections from WT and aP2-VP16-LXRα mice at 
three weeks of age stained with MARCO, SIGN-R1 (MZ macrophages), CD169 (marginal 
metallophilic macrophages) and Laminin (endothelial cells) antibodies (left); scale bar 
represents 25 μm. Right, relative mRNA abundance of ABCA1, CD169, SIGN-R1 and 
MARCO from spleen samples (n = 5) of WT and AP2-VP16-Nr1h3 spleen at three weeks of 
age. Data obtained from two independent experiments with n = 3–5 mice (b) 
Immunohistochemistry analysis of CD169, MARCO and F4/80 expression in spleen 
sections from LXRβ-KO and LXRα-KO mice after clodronate liposome macrophage 
depletion and GW3965 or vehicle control treatment at the indicated times; scale bar 
represents 150 μm. Representative images from 2 independent experiments with n = 5–6 
mice per group are presented.
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